Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced stage Hodgkin lymphoma treated with ABVD chemotherapy: a report from the Indian pediatric oncology group study InPOG-HL-15-01

References

• Kelly KM, Cole PD, Pei Q, et al. Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group. Br J Haematol. 2019;187(1):39–48.
   PubMed Web of Science ®Google Scholar
• Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114(10):2051–2059.
   PubMed Web of Science ®Google Scholar
• Mauz-Körholz C, Hasenclever D, Dörffel W, et al. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol. 2010;28(23):3680–3686.
   PubMed Web of Science ®Google Scholar
• Wolden SL, Chen L, Kelly KM, et al. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma-a report from the Children's Oncology Group. J Clin Oncol. 2012;30(26):3174–3180.
   PubMed Web of Science ®Google Scholar
• Bhethanabhotla S, Jain S, Kapoor G, et al. Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients. Leuk Lymphoma. 2017;58(7):1617–1623.
   PubMed Web of Science ®Google Scholar
• Jain S, Kapoor G, Bajpai R. ABVD-Based therapy for Hodgkin lymphoma in children and adolescents: lessons learnt in a tertiary care oncology center in a developing country. Pediatr Blood Cancer. 2016;63(6):1024–1030.
   PubMed Web of Science ®Google Scholar
• Trehan A, Singla S, Marwaha RK, et al. Hodgkin lymphoma in children: experience in a tertiary care Centre in India. J Pediatr Hematol Oncol. 2013;35(3):174–179.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan V, Dhanushkodi M, Ganesan TS, et al. Pediatric Hodgkin lymphoma treated at cancer institute, Chennai, India: long-term outcome. JGO. 2017;3(5):545–554.
   Google Scholar
• Marr KC, Connors JM, Savage KJ, et al. ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma. Ann Oncol. 2017;28(4):849–854. Apr 1
   PubMed Web of Science ®Google Scholar
• Arora RS, Bakhshi S. Indian pediatric oncology group (InPOG) – collaborative research in India comes of age. Pediatr Hematol Oncol J. 2016;1(1):13–17.
   Google Scholar
• Arora RS, Mahajan A, Dinand V, et al. InPOG-HL-15-01 – challenges and lessons learnt in setting up the first collaborative multicentre prospective clinical trial in childhood cancer in India. Pediatr Hematol Oncol J. 2020;5(4):166–170.
   Google Scholar
• Stiller CA, Kroll ME, Pritchard-Jones K. Population survival from childhood cancer in britain during 1978-2005 by eras of entry to clinical trials. Ann Oncol. 2012;23(9):2464–2469.
   PubMed Web of Science ®Google Scholar
• Hudson MM, Link MP, Simone JV. Milestones in the curability of pediatric cancers. J Clin Oncol. 2014;32(23):2391–2397.
   PubMed Web of Science ®Google Scholar
• Flerlage JE, Kelly KM, Beishuizen A, et al. Staging evaluation and response criteria harmonization (SEARCH) for childhood, adolescent and young adult Hodgkin lymphoma (CAYAHL): methodology statement. Pediatr Blood Cancer. 2017;64(7):e26421.
   Web of Science ®Google Scholar
• Ömür Ö, Baran Y, Oral A, et al. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma. Diagn Interv Radiol. 2014;20(2):185–192.
   PubMed Web of Science ®Google Scholar
• Alnouby A, Ibraheem Nasr IM, Ali I, et al. F-18 FDG PET-CT versus contrast enhanced CT in detection of extra nodal involvement in patients with lymphoma. Indian J Nucl Med. 2018;33(3):183–189.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the lugano classification. J Clin Oncol. 2014;32(27):3059–3068.
   PubMed Web of Science ®Google Scholar
• McCarten KM, Nadel HR, Shulkin BL, et al. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma. Pediatr Radiol. 2019;49(11):1545–1564. Oct
   PubMed Web of Science ®Google Scholar
• Friedman DL, Chen L, Wolden S, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the children’s oncology group study AHOD0031. J Clin Oncol. 2014;32(32):3651–3658.
   PubMed Web of Science ®Google Scholar
• Schellong G, Riepenhausen M, Bruch C, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55(6):1145–1152.
   PubMed Web of Science ®Google Scholar
• Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the childhood cancer survivor study. Blood. 2011;117(6):1806–1816.
   PubMed Web of Science ®Google Scholar
• Dörffel W, Lüders H, Rühl U, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin’s disease in children and adolescents: analysis and outlook. Klin Padiatr. 2003;215(3):139–145.
   PubMed Web of Science ®Google Scholar
• Borchmann P, Goergen H, Kobe C, et al. PET-guided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin study group. Lancet Lond Engl. 2017;390(10114):2790–2802.
   PubMed Web of Science ®Google Scholar
• Casasnovas R-O, Bouabdallah R, Brice P, et al. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study. Lancet Oncol. 2019;20(2):202–215.
   PubMed Web of Science ®Google Scholar
• Hasenclever D, Kurch L, Mauz-Körholz C, et al. qPET – a quantitative extension of the deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41(7):1301–1308.
   PubMed Web of Science ®Google Scholar